Review July 2011: €5.7m funds for research into premature babies
Irish-owned BrePco Biopharma announced that, in conjunction with a consortium of university research centres led by Cork University Maternity Hospital, it had secured €5.7 million in funding to resear
Irish-owned **BrePco Biopharma** announced that, in conjunction with a consortium of university research centres led by Cork University Maternity Hospital, it had secured €5.7 million in funding to research the treatment of critically ill premature newborn babies suffering from hypotension.
It said the collaboration would bring together experts from 13 centres in Ireland, Europe and Canada, to develop a standard of care and uniquely tailored products for treating low blood pressure in such patients. The...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
